Background Licensed mRNA COVID-19 vaccines require booster doses to sustain SARS-CoV-2-specific
responses, creating the need for novel, broadly immunogenic vaccines. We …

After completion of a 6‐week double‐blind trial of asenapine sublingual tablets (10 or 20 mg/day)
versus placebo in Asian patients with acute exacerbation of schizophrenia, including …

Objectives We investigated changes in prescriptions for antimicrobial agents to treat children
with acute otitis media (AOM). Methods A descriptive study using an electronic medical …

Of the many effective vaccines developed to combat the COVID-19 pandemic, the most
notable were novel mRNA vaccines. Despite their high efficacy against the original Wuhan-Hu-1 …

… Taro Kishi, Yasuhiro Iwama, Yuji Sasagawa, Shuichi Hiraoka, Aya Kamei, Nakao Iwata …

Objectives Factors that affect the change of first-line antimicrobial agents were investigated
to further promote their appropriate use. Methods This descriptive study used an electronic …

Aims A meta‐analysis of short‐term studies revealed no significant differences between the
doses of asenapine, 10 and 20 mg/day, in the acute treatment of schizophrenia. However, it …

BackgroundDifferences in psychiatric background and dose–response to asenapine in patients
with schizophrenia were examined based on efficacy and safety, using data obtained in …

Background Licensed mRNA vaccines demonstrated initial effectiveness against COVID-19
but require booster doses to broaden the anti-SARS-CoV-2 response. There is an unmet …

Lowering the carburization temperature of Ti-oxide into TiC down to 1173K could be achieved
by the addition of Co. Co-promoted TiC/SiO 2 catalysts were prepared by the temperature …